Recent extremely meaningful positive changes in fundamentals have benefitted Pediatrix Medical Group Inc (NYSE: MD): the consensus estimate for December, 2025 increased significantly, the stock’s power rating rose above 70, the consensus estimate for December, 2026 increased significantly, and significant quarterly earnings acceleration occurred.
In light of these very positive signals we are reviewing our current Overall Rating of C. We would view the shares with optimism pending completion of this review in the next several days.
Current PriceTarget Research Rating
Pediatrix Medical Group has a current Value Trend Rating of C (High Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing inconsistent signals. Pediatrix Medical Group has a neutral Appreciation Score of 42 but a good Power Rating of 70, producing the High Neutral Value Trend Rating.
Recent Price Action
On 10/13/25, Pediatrix Medical Group Inc (NYSE: MD) stock increased 1.6%, closing at $16.05. However, this advance was accompanied by below average trading volume at 77% of normal. Relative to the market the stock has been strong over the last nine months but has declined -8.3% during the last week.
Be the first to comment